{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:31:47Z","timestamp":1790271107679,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10549-017-4268-7","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T15:52:06Z","timestamp":1494345126000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant\/adjuvant docetaxel chemotherapy"],"prefix":"10.1007","volume":"164","clinical-trial-number":[{"clinical-trial-number":"nct02670603","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ji-Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Nam","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-ju","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hyuck","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"4268_CR1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/annonc\/mdq050","volume":"21","author":"MD Galsky","year":"2010","unstructured":"Galsky MD, Vogelzang NJ (2010) Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol 21:2135\u20132144. doi:10.1093\/annonc\/mdq050","journal-title":"Ann Oncol"},{"key":"4268_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/annonc\/mdw271","volume":"27","author":"MD Hellmann","year":"2016","unstructured":"Hellmann MD, Li BT, Chaft JE, Kris MG (2016) Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol 27:1829\u20131835. doi:10.1093\/annonc\/mdw271","journal-title":"Ann Oncol"},{"key":"4268_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/annonc\/mdh302","volume":"15","author":"MS Mano","year":"2004","unstructured":"Mano MS, Awada A (2004) Primary chemotherapy for breast cancer: the evidence and the future. Ann Oncol 15:1161\u20131171. doi:10.1093\/annonc\/mdh302","journal-title":"Ann Oncol"},{"key":"4268_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1200\/JCO.1999.17.3.1061","volume":"17","author":"C Dumontet","year":"1999","unstructured":"Dumontet C, Sikic BI (1999) Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol 17:1061\u20131070. doi:10.1200\/JCO.1999.17.3.1061","journal-title":"J Clin Oncol"},{"key":"4268_CR5","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa043681","volume":"352","author":"M Martin","year":"2005","unstructured":"Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A, Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C, Breast Cancer International Research Group I (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302\u20132313. doi:10.1056\/NEJMoa043681","journal-title":"N Engl J Med"},{"key":"4268_CR6","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1056\/NEJMoa0910320","volume":"363","author":"M Martin","year":"2010","unstructured":"Martin M, Segui MA, Anton A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodriguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Munoz M, Lopez Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florian J, Li J, Lopez Garcia-Asenjo JA, Saez A, Rios MJ, Almenar S, Peiro G, Lluch A, Investigators G (2010) Adjuvant docetaxel for high-risk, node-negative breast cancer. N Engl J Med 363:2200\u20132210. doi:10.1056\/NEJMoa0910320","journal-title":"N Engl J Med"},{"key":"4268_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.coc.0000026486.56886.18","volume":"26","author":"J Childress","year":"2003","unstructured":"Childress J, Lokich J (2003) Cutaneous hand and foot toxicity associated with cancer chemotherapy. Am J Clin Oncol 26:435\u2013436. doi:10.1097\/01.coc.0000026486.56886.18","journal-title":"Am J Clin Oncol"},{"key":"4268_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","volume":"14","author":"AM Minisini","year":"2003","unstructured":"Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, Puglisi F (2003) Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14:333\u2013337","journal-title":"Ann Oncol"},{"key":"4268_CR9","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1200\/JCO.2006.07.3916","volume":"24","author":"H Roche","year":"2006","unstructured":"Roche H, Fumoleau P, Spielmann M, Canon JL, Delozier T, Serin D, Symann M, Kerbrat P, Soulie P, Eichler F, Viens P, Monnier A, Vindevoghel A, Campone M, Goudier MJ, Bonneterre J, Ferrero JM, Martin AL, Geneve J, Asselain B (2006) Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. J Clin Oncol 24:5664\u20135671. doi:10.1200\/JCO.2006.07.3916","journal-title":"J Clin Oncol"},{"key":"4268_CR10","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","volume":"16","author":"C Robert","year":"2015","unstructured":"Robert C, Sibaud V, Mateus C, Verschoore M, Charles C, Lanoy E, Baran R (2015) Nail toxicities induced by systemic anticancer treatments. Lancet Oncol 16:e181\u2013189. doi:10.1016\/S1470-2045(14)71133-7","journal-title":"Lancet Oncol"},{"key":"4268_CR11","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scotte","year":"2005","unstructured":"Scotte F, Tourani JM, Banu E, Peyromaure M, Levy E, Marsan S, Magherini E, Fabre-Guillevin E, Andrieu JM, Oudard S (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 23:4424\u20134429. doi:10.1200\/JCO.2005.15.651","journal-title":"J Clin Oncol"},{"issue":"Supplement 4","key":"4268_CR12","doi-asserted-by":"publisher","first-page":"iv80","DOI":"10.1093\/annonc\/mdw339.02","volume":"27","author":"CM Fabbro","year":"2016","unstructured":"Fabbro CM, Del Cont L, Polesel J, Tabaro G (2016) Efficacy of cryotherapy in paclitaxel-induced nail toxicity: preliminary results from a Phase II clinical study. Ann Oncol 27(Supplement 4):iv80\u2013iv84. doi:10.1093\/annonc\/mdw339.2","journal-title":"Ann Oncol"},{"key":"4268_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.13743","volume":"173","author":"K Capriotti","year":"2015","unstructured":"Capriotti K, Capriotti JA, Lessin S, Wu S, Goldfarb S, Belum VR, Lacouture ME (2015) The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis. Br J Dermatol 173:842\u2013845. doi:10.1111\/bjd.13743","journal-title":"Br J Dermatol"},{"key":"4268_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cncr.23333","volume":"112","author":"F Scotte","year":"2008","unstructured":"Scotte F, Banu E, Medioni J, Levy E, Ebenezer C, Marsan S, Banu A, Tourani JM, Andrieu JM, Oudard S (2008) Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer 112:1625\u20131631. doi:10.1002\/cncr.23333","journal-title":"Cancer"},{"issue":"1","key":"4268_CR15","first-page":"28","volume":"6","author":"J-F Chanez","year":"2010","unstructured":"Chanez J-F (2010) The neurogenic component of cutaneous toxicities induced by chemotherapy\u2014new solutions. Euro Oncol 6(1):28\u201330","journal-title":"Suppor Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-017-4268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:44:52Z","timestamp":1628610292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-017-4268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4268"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4268-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]},"assertion":[{"value":"19 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}